(VIANEWS) – STRONGPOINT (STRO.OL), SPBK1 HELGELAND (HELG.OL), UCB (UCB.BR) are the highest payout ratio stocks on this list.
We have congregated information concerning stocks with the highest payout ratio up until now. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. STRONGPOINT (STRO.OL)
169.81% Payout Ratio
StrongPoint ASA engages in the development, sale, and implementation of integrated technology solutions for stores and e-commerce operations in Norway, Sweden, and internationally. It offers various products and solutions comprising electronic shelf labels, scales and wrapping systems, and grocery robots; order and in-store picking, home delivery, grocery lockers, drive-through, and autostore microfulfilment solutions; cash management systems; and shop fitting services, as well as other retail technology and self-checkout solutions. The company also provides ShopFlow Logistics, a cloud based mobile logistics system for handling routines that include receiving goods, inventory, balance adjustment, ordering labels printing, and waste management; and Vensafe, which automates in-store sales of restricted and theft-prone products. It has a strategic partnership with Halodi Robotics to develop robotic solutions for the grocery retail sector. The company was formerly known as PSI Group ASA and changed its name to StrongPoint ASA in September 2015. StrongPoint ASA was incorporated in 2000 and is headquartered in Rælingen, Norway.
Earnings Per Share
As for profitability, STRONGPOINT has a trailing twelve months EPS of kr0.53.
PE Ratio
STRONGPOINT has a trailing twelve months price to earnings ratio of 35.75. Meaning, the purchaser of the share is investing kr35.75 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.94%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 0.9 and the estimated forward annual dividend yield is 4.81%.
Yearly Top and Bottom Value
STRONGPOINT’s stock is valued at kr18.95 at 12:10 EST, way under its 52-week high of kr27.65 and way higher than its 52-week low of kr16.00.
Sales Growth
STRONGPOINT’s sales growth for the current quarter is 18.6%.
Volume
Today’s last reported volume for STRONGPOINT is 760 which is 96.86% below its average volume of 24217.
More news about STRONGPOINT.
2. SPBK1 HELGELAND (HELG.OL)
75.44% Payout Ratio
SpareBank 1 Helgeland provides various financial products and services to retail customers, small and medium enterprises, municipal authorities, and institutions in Norway. The company operates in two segments, Retail Market and Corporate Market. It offers savings, investment, and insurance products, as well as leasing and mortgage services. The company is also involved in owning, managing, and letting commercial properties. It operates through branches located in Mosjøen, Brønnøysund, and Sandnessjøen. The company was founded in 1860 and is headquartered in Mo i Rana, Norway.
Earnings Per Share
As for profitability, SPBK1 HELGELAND has a trailing twelve months EPS of kr13.6.
PE Ratio
SPBK1 HELGELAND has a trailing twelve months price to earnings ratio of 9.34. Meaning, the purchaser of the share is investing kr9.34 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.14%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 1B for the twelve trailing months.
Yearly Top and Bottom Value
SPBK1 HELGELAND’s stock is valued at kr127.00 at 12:10 EST, under its 52-week high of kr140.00 and way above its 52-week low of kr103.00.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 90.5% and 55%, respectively.
More news about SPBK1 HELGELAND.
3. UCB (UCB.BR)
60.47% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €2.15.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 37.9. Meaning, the purchaser of the share is investing €37.9 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.81%.
Moving Average
UCB’s value is under its 50-day moving average of €81.96 and higher than its 200-day moving average of €79.45.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 1.33 and the estimated forward annual dividend yield is 1.62%.
More news about UCB.
4. HEINEKEN HOLDING (HEIO.AS)
31.33% Payout Ratio
Heineken Holding N.V., through its subsidiaries, engages in brewing and selling beer and cider in the Netherlands and internationally. The company's portfolio consists of approximately 300 international, regional, local, and specialty beers and ciders. The company was founded in 1864 and is based in Amsterdam, the Netherlands. Heineken Holding N.V. is a subsidiary of L'Arche Green N.V.
Earnings Per Share
As for profitability, HEINEKEN HOLDING has a trailing twelve months EPS of €4.66.
PE Ratio
HEINEKEN HOLDING has a trailing twelve months price to earnings ratio of 16.24. Meaning, the purchaser of the share is investing €16.24 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.6%.
Yearly Top and Bottom Value
HEINEKEN HOLDING’s stock is valued at €75.70 at 12:10 EST, way under its 52-week high of €88.85 and way higher than its 52-week low of €62.90.
Volume
Today’s last reported volume for HEINEKEN HOLDING is 4919 which is 96.36% below its average volume of 135257.
More news about HEINEKEN HOLDING.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
More news about 1.
